BioCentury | Nov 17, 2017
Company News
CRISPR, Casebia get rights to CureVac editing constructs
...immunosuppressive activity than unmodified Tregs (see BioCentury Innovations, Nov. 2 ). In September, Casebia and Seattle Children's Research Institute...
...Basel, Switzerland Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Gene/Cell therapy Elizabeth S. Eaton Bayer AG CRISPR Therapeutics AG CureVac AG Seattle Children's Research Institute Casebia...
...Basel, Switzerland Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Gene/Cell therapy Elizabeth S. Eaton Bayer AG CRISPR Therapeutics AG CureVac AG Seattle Children's Research Institute Casebia...